Cerus (CERS) Total Debt Growth (3y) (2013 - 2026)
Cerus (CERS) Total Debt Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.40 Bn | 176.11 Bn | 6.27 Bn | 26.30% |
| 2 | Stryker | 128.93 Bn | 126.05 Bn | 3.81 Bn | 4.07% |
| 3 | Medtronic | 108.35 Bn | 99.13 Bn | 6.41 Bn | 4.70% |
| 4 | Boston Scientific | 68.71 Bn | 67.25 Bn | 3.61 Bn | 6.99% |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.68 Bn | 1.29 Bn | 0.11% |
| 6 | Dexcom | 28.37 Bn | 27.25 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.04 Bn | 25.76 Bn | 1.98 Bn | -0.32% |
| 8 | Smith & Nephew | 26.90 Bn | 26.33 Bn | - | 5.42% |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | 2.61% |
| 10 | Cerus | 602.81 Mn | 522.39 Mn | 27.89 Mn | 5.22% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.22% |
| Dec 31, 2025 | 6.32% |
| Sep 30, 2025 | 6.78% |
| Jun 30, 2025 | 6.77% |
| Mar 31, 2025 | 6.79% |
| Dec 31, 2024 | 6.63% |
| Sep 30, 2024 | 8.84% |
| Jun 30, 2024 | 9.32% |
| Mar 31, 2024 | 9.58% |
| Dec 31, 2023 | 18.38% |
| Sep 30, 2023 | 20.84% |
| Mar 31, 2023 | 18.05% |
| Dec 31, 2022 | 16.25% |
| Sep 30, 2022 | 16.27% |
| Jun 30, 2022 | 16.75% |
| Mar 31, 2022 | 20.95% |
| Dec 31, 2021 | 32.46% |
| Sep 30, 2021 | 29.39% |
| Jun 30, 2021 | 28.98% |
| Mar 31, 2021 | 29.37% |